Corporate News AbbVie in charts: Revenues from Humira -49%, Skyrizi +57.8%, Rinvoq +46% Y/Y by Contributor since / Followers 2 months ago Tags: ABBV Continue Reading Previous Exxon edges higher as Q4 earnings top consensus; Permian, Guyana production hits recordNext Earnings Snapshot: AbbVie Q4 top-line beats estimates; 2025 EPS outlook beat expectations Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
